GX EJ7 (Epivir 300 mg)
Generic Name: lamivudine
Pill imprint GX EJ7 has been identified as Epivir 300 mg.
Epivir is used in the treatment of hepatitis b; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Epivir 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- lamivudine
- Imprint:
- GX EJ7
- Strength:
- 300 mg
- Color:
- Gray
- Size:
- 17.00 mm
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0714
- Inactive Ingredients:
- ferric oxide black
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
More about Epivir (lamivudine)
Consumer resources
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
